Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...
Soft tissue sarcomas (STS) are rare malignant tumors arising from connective tissues such as muscle, fat, and blood vessels, ...
The Food and Drug Administration granted accelerated approval for Adaptimmune Therapeutics’ cell therapy Tecelra in treating a specific form of cancer. The drug is on track to treat patients with ...
A new study published today in Cancer Discovery, a journal of the American Association for Cancer Research, reports findings that may change the understanding of how synovial sarcoma develops and ...
Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma - a rare tumor of soft tissues, such as ligaments and muscles - using an ...
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Synovial Sarcoma pipeline constitutes 15+ key companies continuously working towards developing 20+ Synovial Sarcoma ...
Brazilian singer Vanessa Rios passed away at 42 after a brave fight with pulmonary synovial sarcoma. Her death has deeply ...
The FDA has approved the gene therapy Tecelra for treatment of synovial sarcoma. Tecelra, developed by biopharmaceutical company Adaptimmune, is the first gene therapy treatment for adult patients ...
Patients with advanced synovial sarcoma may have a new therapy option if the novel drug, afami-cel, is approved by the FDA after the priority review. The Food and Drug Administration (FDA) has ...
The federal government has been closed for business for nearly a month and federal employees across the nation are feeling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback